BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12587125)

  • 1. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
    Kossena GA; Boyd BJ; Porter CJ; Charman WN
    J Pharm Sci; 2003 Mar; 92(3):634-48. PubMed ID: 12587125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.
    Boyd BJ; Porter CJ; Charman WN
    J Pharm Sci; 2003 Jun; 92(6):1262-71. PubMed ID: 12761815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
    Williams HD; Anby MU; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Pouton CW; Porter CJ
    Mol Pharm; 2012 Nov; 9(11):3286-300. PubMed ID: 23030411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
    Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
    Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
    Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
    Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.
    Devraj R; Williams HD; Warren DB; Mullertz A; Porter CJ; Pouton CW
    Int J Pharm; 2013 Jan; 441(1-2):323-33. PubMed ID: 23178598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
    Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
    Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
    Phan S; Salentinig S; Hawley A; Boyd BJ
    Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note.
    Lee YC; Dalton C; Regler B; Harris D
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1551-1556. PubMed ID: 29873584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of drug solubilization by polar lipids in biorelevant media.
    Katev V; Vinarov Z; Tcholakova S
    Eur J Pharm Sci; 2021 Apr; 159():105733. PubMed ID: 33497822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo.
    Müllertz A; Fatouros DG; Smith JR; Vertzoni M; Reppas C
    Mol Pharm; 2012 Feb; 9(2):237-47. PubMed ID: 22136289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
    Vithani K; Jannin V; Pouton CW; Boyd BJ
    Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N; Bergström CA; Kuentz M
    Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs.
    Nielsen PB; Müllertz A; Norling T; Kristensen HG
    Int J Pharm; 2001 Jul; 222(2):217-24. PubMed ID: 11427352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.
    Kleberg K; Jacobsen F; Fatouros DG; Müllertz A
    J Pharm Sci; 2010 Aug; 99(8):3522-32. PubMed ID: 20564382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digestion of phospholipids after secretion of bile into the duodenum changes the phase behavior of bile components.
    Birru WA; Warren DB; Ibrahim A; Williams HD; Benameur H; Porter CJ; Chalmers DK; Pouton CW
    Mol Pharm; 2014 Aug; 11(8):2825-34. PubMed ID: 24987935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.